VitVio, a London, UK-based company empowering surgical efficiency, patient outcomes, and hospitals’ ROI, raised $2M in Pre-Seed funding.
The round was led by LDV Capital with participation from Bek Ventures (ex-Earlybird), Tiny Supercomputer Investment Company, and angel investors.
The company intends to use the funds to extend the capabilities of its platform and deploy the technology at partner hospitals.
Co-founded by Thomas Knox (CEO), Dr. Peter Rennert (CTO), Maks Kozarzewski (COO) and Aleks Pajewski (CPO), VitVio autonomously tracks and analyzes surgical procedures, tool usage, and adherence to protocols in real-time – increases the number of surgeries performed per day, reduces delays, improves communication actionability, and reduces the likelihood of readmissions.
Post-surgery VitVio provides detailed reports, identifying successes and opportunities for improvement, and encouraging continuous learning opportunities. These insights fuel debriefing sessions for surgical teams to review performance, address flagged issues, and plan enhancements. Cumulative data gathered by VitVio aids in understanding surgical operations and guiding evidence-based strategies to improve efficiency, reduce costs, and elevate patient safety.
FinSMEs
08/01/2025